Australian University Rankings Guide

Infectious diseases and therapy (ERA Journal)

Infectious diseases and therapy is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Infectious diseases and therapy issns are issn1: 2193-6382 issn2: 2193-8229.

The fields covered by Infectious diseases and therapy as part of the evaluation of Australian university research excellence are:

Clinical Sciences Research Rankings (Sub-Field)

Immunology Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Clinical Sciences field include:

- AIDS Research and Human Retroviruses
- Advances in Gerontology
- Alcoholism: Clinical and Experimental Research
- Anadolu Psikiyatri Dergisi
- Annales d'Endocrinologie
- Applied Radiation and Isotopes
- Archivio Italiano di Anatomia e di Embriologia
- Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Current Diabetes Reports
- European Journal of Trauma and Emergency Surgery
- Journal of American Association for Pediatric Ophthalmology and Strabismus
- Journal of Global Infectious Diseases: translating science from benchside to bedside and beyond
- Journal of Nutritional and Environmental Medicine
- Physical and Occupational Therapy in Geriatrics: current trends in geriatric rehabilitation
- Stroke

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4